Product Code: ETC9978095 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Thrombin Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Thrombin Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Thrombin Market - Industry Life Cycle |
3.4 United States (US) Thrombin Market - Porter's Five Forces |
3.5 United States (US) Thrombin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Thrombin Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Thrombin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing number of surgical procedures in the US |
4.2.2 Rising prevalence of chronic diseases requiring surgical interventions |
4.2.3 Technological advancements in thrombin products |
4.2.4 Growing demand for hemostatic agents in healthcare settings |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for product approval |
4.3.2 High cost associated with thrombin products |
4.3.3 Limited awareness about thrombin-based products among healthcare professionals |
4.3.4 Potential risks of adverse reactions or complications associated with thrombin use |
5 United States (US) Thrombin Market Trends |
6 United States (US) Thrombin Market, By Types |
6.1 United States (US) Thrombin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Thrombin Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Thrombin Market Revenues & Volume, By 500IU/Vial, 2021- 2031F |
6.1.4 United States (US) Thrombin Market Revenues & Volume, By 1000IU/Vial, 2021- 2031F |
6.1.5 United States (US) Thrombin Market Revenues & Volume, By 2500IU/Vial, 2021- 2031F |
6.2 United States (US) Thrombin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Thrombin Market Revenues & Volume, By Biotechnology, 2021- 2031F |
6.2.3 United States (US) Thrombin Market Revenues & Volume, By Medicine, 2021- 2031F |
6.2.4 United States (US) Thrombin Market Revenues & Volume, By Microbiology, 2021- 2031F |
6.2.5 United States (US) Thrombin Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Thrombin Market Import-Export Trade Statistics |
7.1 United States (US) Thrombin Market Export to Major Countries |
7.2 United States (US) Thrombin Market Imports from Major Countries |
8 United States (US) Thrombin Market Key Performance Indicators |
8.1 Adoption rate of thrombin products in US hospitals and surgical centers |
8.2 Number of research and development initiatives focused on improving thrombin products |
8.3 Rate of successful clinical outcomes reported with the use of thrombin products |
9 United States (US) Thrombin Market - Opportunity Assessment |
9.1 United States (US) Thrombin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Thrombin Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Thrombin Market - Competitive Landscape |
10.1 United States (US) Thrombin Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Thrombin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |